Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 377,830 | 0 | 0 | 0 |
| Depreciation Amortization | 0 | 493,190 | 0 | 0 | 0 |
| Other Working Capital | 0 | -26,950 | 0 | 0 | 0 |
| Other Operating Activity | 0 | -34,940 | 0 | 0 | 0 |
| Operating Cash Flow | $0 | $809,130 | $0 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -99,290 | 0 | 0 | 0 |
| Net Acquisitions | 0 | -20 | 0 | 0 | 0 |
| Other Investing Activity | 0 | -52,570 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $-151,880 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -627,260 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $-627,260 | $0 | $0 | $0 |
| Exchange Rate Effect | 0 | -4,790 | 0 | 0 | 0 |
| Beginning Cash Position | 0 | 813,560 | 0 | 0 | 0 |
| End Cash Position | 0 | 838,760 | 0 | 0 | 0 |
| Net Cash Flow | $0 | $25,190 | $0 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 809,130 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 809,130 | 0 | 0 | 0 |